Product: Machinery for Filling, Closing, Sealing, Capsuling or Labelling Bottle

(HS Code: 842230)

(Submitted by: Adhinayak Gohar, Roll No. 01, MBA (PT) 20112014) Introduction
a)

Filling Machines : Filling machine is one of and one of the most important equipment from
pakaging machinery.It is mainly divided into 3 according to liquid filling theory: atmospherical pressure filling machine, pressure filling machine and vacuum filling machine. Bottled drinking water adopts atmospherical pressure filling, that is gravity filling; and the same to juice, but some juice filling needs hot filling. Bottled soft drinks (carbonated drinks) adpots pressure filling because the filling process would be finished over atmospheric pressure. It is divided into such 2 ways: Pressure from liquid storage in cylinder and pressure from the bottles is equal, this is isobar filling. The other one is pressure from liquid storage in cylinder is higher than pressure from bottles. Most production line with high speed uses this filling way. Pressure filling is mainly used to carbonated drinks filling, such as soft drinks, carbonated drinks, beer and champagne and so on.

b) Closing, Capping & Sealing Machines : The capping machines are used in the application of plastic and metal threaded caps as well as plastic snap caps. Designed and built to the highest standards from the finest components, our capping machines incorporate innovative features and improvements based on a deep understanding of users' requirements gained from our years of experiences.Automatic linear and semi-automatic capping machines to meet every requirement for those who need higher speed production capacity. Capping machines utilize the latest technologies to achieve the highest speeds and most accurately capped bottles on the market.

c) Capsuling Machines : Capsule machines are available for filling 50, 100, and 300 capsules at a time. Each manufacturer's machine is slightly different in its operation, but the series of operations is the same. Capsules are first loaded into the machine. Most machines come with a capsule loader which correctly aligns all of the capsules in the machine base. There are plates on the machine base that can be adjusted. First, the plates are adjusted to hold the capsule bodies in place while the caps are removed all at one time. The caps remain in place in the top of the machine for later use. Then the plates are adjusted again so that the capsule bodies will "drop" into place so that the tops are flush with the working surface of the plate. The formulation powder is poured onto the plate and special spreaders and combs are used to fill the individual capsules. Some manufacturer's have special shakers that will also help spread the powder and fill the capsules. The powder is spread evenly over the plate, and the comb is used to tamp and pack the powder into the capsules. These two processes are repeated over and over again until the capsule bodies are filled with the powder. All of the caps are then simultaneously returned to the capsule bodies, and the closed capsules are removed from the machine.

d) Labelling Machines: labelling machines in various working environment. We offer cost effective labelling machines solutions for all your labelling needs. As an experienced manufacturer in labeling bottles, we offer high quality labelling on a wide variety of packaging. To ensure smoothness and reliability in machines operations, our labelling machines are conceived with the most practical design and built quality. The labelling machines are suitable for bottles and containers of glass, plastic, metal or any other more or less rigid material.

National Packaging Machines Scenario Growth of Indian Packaging Machinery : India currently accounts for 8% of the
world's pharmaceutical production share in volume terms. The country is the producer of over 60,000 formulations, 900 types of bulk drugs and around 1,200 drug intermediaries. There are around 15,000 pharma manufacturers in India, of which 8200 manufacture formulation drugs and the balance bulk drugs However, the top 10 players account for over 60% of the bulk drugs market and over 30% of formulations. The pharmaceutical packaging sector in India is characterized primarily by blister packaging machinery, small scale blister packaging machinery, de-blistering machines and leak testing machinery. The dedicated production capacities of large players in the packaging sector contribute to nearly 50% of the entire market. The report released on Opportunity in the Blister Packaging Machinery Sector in India 2013 aims to go beyond the obvious information available in the secondary domain. It provides information through extensive secondary and primary research, coupled with analytics, to clear all ambiguity in the minds of the market stakeholders. The findings will be of particular interest to pharmaceutical firms, packaging machinery manufacturers and consultants, among others. This research report will provide an insight into the Opportunity in the Indian Blister Packaging Machinery, the current market scenario, structure and practices. In depth market scenario would detail the Installed base of machinery, All India market size, including market size by product categories - Blister packaging machinery, Small scale blistering machinery, De-blistering machine and Leak testing machinery. Market structure would outline the Usage Trends & Practices of blister packing machines, de-blistering machines and leak testing machines, while Market practices would include understanding the Opportunity in the Indian Blister Packaging Machinery business, market trends, distribution practices and pricing.

Pharmaceutical Machineries: Global Market

The pharmaceutical machineries made by India are installed and under operations at all the FDA Approved manufacturing facilities in USA, Australia, Africa, etc. meeting the parameters of complete satisfactions. The high credentials goes to strict quality standards adopted by the pharmaceutical machinery manufacturers in India, which had lead some of the Indian companies have entered in to the technical tie-ups / joint ventures with USA, Europe and South East Asian companies to manufacture their products in India and being marketed in all Asian and CIS counties. Emerging markets such as China, Russia, Turkey and Korea had double digit growth, contributing significantly to this large growth rate. In the next five years, world pharmaceutical market alone is poised grow at a rate of 8 percent with business opportunity of over a US$ trillion. Countries like USA, Japan and those of Europe led by Germany shall remain dominant market controlling over 80 percent trade opportunities. Asian countries like South Korea, Taiwan and India are expected to have growth rates ranging from 12 to 15 percent annually. The new product patent regime and increased proportion of Indian pharmaceutical exports to advanced markets is gearing Indian pharma machinery manufacturers to better GMP and higher technological adaptation. Indian machinery companies have started to follow proper documentation and maintenance of records for every manufacturing and maintenance procedure, which is demanded by international buyers. Indian machinery manufacturers are perfectly evolving with changing times. Today, Indian machines are far better in quality and in par with international standards, than it used to be 15 years ago. Indian manufacturers follow the ISO 14000 and 9001 series of quality certification. Due to industry trends such as off-

shoring and outsourcing, there are an increasing number of pharmaceutical manufacturers in Asia, and instrument providers are keen to take advantage of this booming market. North America remains the largest Pharmaceutical market constituting 49% of the worldwide market followed by Europe and Asia-Pacific. Pharmaceutical market across the world is witnessing increased opportunities in the area of Bio Pharmaceuticals, Pharmacogenomics and Biologics market. The smaller national markets in Asia-Pacific and Latin America are expected to grow significantly and will increase their presence in the global Pharmaceutical landscape. The top big players now are concentrating on the regulated US and European markets, giving their local giants a run for their money. It is common knowledge that USA and Europe take up the lion's share of around 80% of the global pharma market. The model keeps on upgrading the total culture of the industry and encouraging the medium companies to enter the export market. The entry of the top companies in the regulated markets and their success in the generic market has become benchmark for all the small & mid-size companies. The phenomenal growth of these companies & growing profit margins means a bonanza for their stockholders, fuelling fresh investment in the Industry. In terms of pharmaceutical packaging, there is robust growth ahead for this sector. The global pharmaceutical and healthcare packaging market will grow with a compound annual growth rate (CAGR) of 6.2 % in 2009. With approximately 34 % of the share, North America is still the largest market, followed by Western Europe with 29 % and Asia with 24 %. Eastern Europe's share is relatively low at 4.5 % but expected to increase above average to 5.3 % in 2009. The pharmaceutical packaging technology market is estimated to grow by 4.3 % until 2009. The U.S. pharmaceutical industry has achieved worldwide prominence through research and development (R&D) work on new drugs, and spends a relatively high proportion of its funds on R&D compared with other industries.

India: The Market Place

Indian pharmaceutical industry is not only one of the fastest growing sectors of Indian economy but also a leading player in the world - ranking 4th in volume and 13th in value terms. With an annual turnover of Rs 1,500 crore and growing at over 10% per annum Indian pharmaceutical machinery manufacturing sector constitutes around 5% of the global market in value terms. The rise in joint ventures between foreign and Indian pharma companies proves that India can make world-class products at affordable prices. There are also significant opportunities for pharmaceutical plant design consultancy and related services especially for large companies adapting to USFDA, UKMCC standards. Overall, being the lowest cost producer combined with FDA approved plants, India promises to be a global outsourcing hub for pharmaceutical products. Figures on Pharmaceutical Machinery Rs 1,500 crores - Estimated market 10% - Rate of growth 400 - Organised machinery makers Rs 200 crores - Export of machines/year 5% - Annual import

Indian Machinery Export and Import Trade Flow

Indian Cotton Export and Import Trade Flow : During the 1960s and early 70s, the pharmaceutical industry in India was heavily dependent on imported machines from Europe for its processing and packaging needs. Among the major foreign companies that supplied this machinery were Aeromatic, Fete, Glatt, Hassia, Hofliger & Karg, Kilian, Manesty, Sparkler, Stunk and Zanasi, all very well known for their technological excellence in their respective fields. However, the mid-70s saw the country going through a severe shortage of foreign exchange and, therefore, the Indian government introduced very high import duties and restrictive import licensing policies, resulting in steep rise in prices of imported machinery. Pharmaceutical companies, therefore, compelled to look elsewhere for their machine requirements, encouraged Indian engineering enterprises to manufacture machines locally. This was perhaps the only route for the pharmaceutical industry to enhance production and cater to the growing demands of the domestic market. And, needless to say, this was a great and challenging opportunity for the Indian small-scale engineering companies. Thus a scenario was created whereby hundreds of machinery manufacturers mushroomed to cater to the needs of numerous pharmaceutical companies over a period of time. It is the initiative of these Indian engineer entrepreneurs that has today resulted in Indian pharmaceutical manufacturing costs being much lower than other developing countries, not to talk of Europe and the US. This was made possible by the huge savings on capital investment of plant and machinery, besides the cheapter technical manpower costs. Pharmaceutical machineries made by India are installed and under operations at FDA-approved manufacturing facilities in the US, Australia, Africa, etc. meeting international standards and parameters to complete satisfaction. As these countries mandate proper validation of the products the importance of machinery that incorporate advanced technologies are also increasing For validation of the products, the machine also should be fully equipped. The credit for the high credentials goes to the strict quality standards adopted by pharmaceutical machinery manufacturers in India. This has helped many Indian companies to enter into technical tie-ups joint ventures with American. European and Southeast Asian companies for the manufacture of their products in India, which are being marketed in all Asian and CIS countries Now the machine manufacturers are upgrading themselves by investing in knowledge. Many pharmaceutical machinery manufacturers have begun to visit various countries to observe and learn about the latest developments in technology to improve their production line. In addition to this, there are other visible trends that further reflect the commitment to excellence of Indian machinery manufacturers. Some of these are listed here: Machine-makers are increasingly upgrading and moving towards computerisation, using CNC machines and incorporating precision instruments such as VFD, PLC, etc. in their products to get quality output. More and more firms are opting for ISO approval. Manufacturers are importing proto type machines. CE approval for products is being sought. Firms are going in for collaborations and technology transfer. Manufacturing units are steadily expanding to meet the rising global demand. Firms are investing in HRD by engaging professionals to meet the challenges of the international market.

Evidently, Indian pharmaceutical machines, which have already made a dent on domestic soil, have also started making considerable inroads into the international market as well The growing acceptance of Indian machines in foreign countries is illustrative of this trend.

In India. there are more than 800 units manufacturing pharmaceutical machinery, comprising small, medium and large-scale enterprises, with an estimated turnover of Rs. 2,000 crore, of which around 40 percent is being exported to more than 80 countries around the world, including the US, UK and other European countries. The Indian pharmaceutical machinery manufacturing sector constitutes around 5-7 percent of the global market in value terms. The rise in joint ventures between foreign and Indian pharmaceutical companies proves that India can make world-class products at affordable prices. There are also significant opportunities for pharmaceutical plant design consultancy and related services, especially for large companies adopting USFDA and UKMCC standards. Overall, being the lowest cost producer combined with FDA-approved plants, India promises to be a global outsourcing hub for pharmaceutical products. Looking at the capabilities of Indian engineering companies, many international machine manufactures have joined hands with them, which has helped the Indian pharmaceutical industry to make further advancements in their products and, at the same time, supplying machinery at a price at least one-fourth or one-third of imported machines. Government Initiatives The Indian Pharma Machinery Manufacturers Association (IPMMA) is committed to achieving common goals whereby the benefits can be shared by all members of the association. Indian pharmaceutical machinery manufacturers have been one of the key contributors to the growth of the Indian pharmaceutical and drug industry and, therefore, the association has made all-out efforts to understand the need for upgrading the manufacturing, designing, marketing and banking skills that are required by the industry and tries to render help to small members to help them grow corresponding with the growth of the pharmaceutical industry. However, the fruits go these efforts will be visible only over the next few years as the association grows in size to handle such major responsibilities. The association is in the process of coordinating with various agencies. component suppliers, etc. to impart necessary knowledge to its members under a single-roof programmer. This will help both the supplier as well as the industry, saving time and money for all parties concerned. The association also arranges various technical seminars to raise awareness among its members of latest developments. Today, IPMMA has more than 250 member companies on its rolls and it has been recognised by several governments, semi-governments and trade councils. It is a great pride for the association that these members already export their products to 80 countries spread across five continents and, therefore. the association is i intensifying its efforts to support the nonexporting members in finding overseas markets. IPMMA is committed to explore various avenues to organise technologically educative conferences seminars so as to instil a sense of confidence among its members. Driven by passion for excellence, the association is trying to build an environment that fosters learning, innovation, growth. excellence and a culture that is focused towards achieving solutionoriented results and sustained growth for its members.

Challenges & Recommendations : In general, the pharma industry has always been on the lookout for innovative packaging in terms of convenience, customer friendliness and more importantly hygiene and compatibility with the products. In view of these aspects, there have been enormous developments in packaging especially to restrict counterfeiting. Today pharmaceutical packaging has gone a long way with the introduction of new kinds of speciality packs with single dose, multi-dose as well as multi-purpose packaging. It is observed that new kinds of innovative techniques like

bar coding, RFID (Radio Frequency Identification Drivers) have been introduced to solve the problems of anti-counterfeiting. In addition, many more developments, especially in the Caps and Closures sector have also evolved where child resistant closures, senior citizen customerfriendly closures have being introduced by the packaging industry in order to meet the requirements of convenient and economic packaging. The Indian Institute of Packaging has set up testing laboratories for the testing of different types of packaging materials in order to asses the quality of packaging materials and packages. The Institute has also introduced various important tests like the migration test as per FDA (Food and Drug Administration Act) in order to asses the quality of packaging materials. The Institute is also involved in the formulation of various standards related to packaging published by BIS (Bureau of Indian Standards) and other statutory bodies. Yes. The Institute is one of the founder members of World Packaging Organisation (WPO), a global non-profit making apex body constituted by leading packaging Institutions globally. IIP is also a Board Member of the WPO and actively works with the organisation for the promotion of packaging techniques besides creating awareness in packaging by organising global training programmes with the assistance of WPO. Similarly, the Institute is also the founder member of the Asian Packaging Federation (APF), an international organisation consisting of 14 Asian Pacific countries involved with the promotion of packaging in this particular region. The director of IIP is a board member and also the chairman of the education committee of APF which has been taken up many initiatives like training activities within the South East Asian Countries. IIP receives a multitude of samples of packaging from MNCs, pharmaceutical industries and also from overseas companies for the quality evaluation of packaging materials. The Institute is having a dialogue with the All India Pharmaceutical Manufacturers Association as well as the Pharmaceutical Export Promotion Council to advise them about the formulation of specifications for Uni-packs as well as bulk packs in order to reduce the transit loss of pharmaceutical packaging. Today, India is a global hub for bulk drugs and the graph is rising and is expected to show positive trends even in the near future. Hence, there is an urgent need to upgrade the standards of packaging along with the quality of the pharma products. Even though the country has been doing extremely well in the export of bulk drugs, etc. there is a need to upgrade the standard even more so that in the future, India would be leading in the export of pharmaceutical products. The Institute is involved in the promotion of export of bulk drugs by way of issuing UN certificates as authorized by the Government of India, as most of the bulk drugs are covered with hazardous chemicals. Since the Institute is the only authority issuing UN Certificates, the Institute plays a vital role in the export of pharmaceutical products and thus develops the export market.